Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer.

Radiat Oncol · 2024 · PMC10868020 · PMID 38355495

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In this study, the single fraction SABR regimen was associated with a lower incidence of CKD stage 4–5 compared to multi-fraction SABR on univariable analysis ( p = 0.005), though this did not reach statistical significance on multivariable analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.